Wednesday, 19 April 2006, Hall 10, ICC Birmingham
We have endeavored to ensure a strong clinical emphasis, and an excellent line-up of speakers from both the US and Europe:
| PROGRAMME |
| 8:30 - 9:00 |
Registration |
| 9:00 - 9:25 |
Update on NT pro-BNP research
Adrian Boswood, RVC |
| 9:25 - 10:25 |
NOVARTIS SOTA lecture
Management of asymptomatic chronic mitral valve disease in dogs
Clarke Atkins, USA |
| 10:25 - 10:50 |
Clinical efficacy of pimobendan in comparison to benazepril and metildigoxin in Irish wolfhounds with preclinical DCM. Interim analysis after year 4 of the study
Andrea Vollmar, Germany
Sponsored by Boehringer Ingelheim |
| 10:50 - 11:20 |
Coffee Break |
| 11:20 - 11.45 |
Update on the reliability regarding the detection of systemic hypertension - latest research findings
Beate Egner, Germany |
| 11:45 - 12:15 |
Assessment of cardiovascular disease in 555 boxer dogs
Andrea Vollmar, Germany
Sponsored by Boehringer Ingelheim |
| 12:15 - 12:45 |
Survival characteristics in >1000 Irish wolfhounds. Prevalence of DCM and effect on life expectancy
Andrea Vollmar, Germany
Sponsored by Boehringer Ingelheim |
| 12:45 - 2:00 |
Lunch |
| 2:00 - 2:25 |
Heart failure in feline diabetics
Chris Little, Kent |
| 2:25 - 2:45 |
Case report - Right-to-left shunting patent ductus arteriosus in a cat
Yolanda Pereira, University of Edinburgh |
| 2:45 - 3:30 |
Pathology and histopathology of feline cardiomyopathies
Phil Fox, USA |
| 3:30 - 4:00 |
Coffee |
| 4:00 - 5:00 |
Panel Discussion: How Do The Experts Treat CHF?
Clarke Atkins, Phil Fox, Mark Patteson, Paul Wotton |
| COST |
£85 for members of the VCS, registering before March 17th
£95 for non-members, registering before March 17th
£110 for any delegates registering after March 17th |
|